Af de 28 voksne og unge i den anden undersøgelse, hos hvem mindst to andre behandlinger havde svigtet, viste fem (18%) fuldstændig respons.
In the second study, among the 28 adults and adolescents who had failed two or more previous treatments, five (18%) had a complete response to treatment.